Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003

The Journal of Antimicrobial Chemotherapy
Sally A RobertsArthur J Morris

Abstract

Routine susceptibility testing of all anaerobic organisms is not advocated, but it is useful for laboratories to test periodically for anaerobic organisms and provide local susceptibility data to guide therapy. This study reports the national trend of antibiotic susceptibility of clinically significant anaerobes in New Zealand. Clinical isolates were tested using standardized methods against a range of antibiotics commonly used to treat anaerobic infections. Susceptibility was determined using NCCLS criteria. The change in susceptibility trends between this study and earlier studies was measured by comparing the geometric mean of the MIC. A total of 364 anaerobes were tested. Penicillin had poor activity against Bacteroides spp., Prevotella spp., Eubacterium spp., Clostridium tertium and Veillonella spp. In general, Fusobacterium spp., Bacteroides ureolyticus, Propionibacterium spp., Clostridium perfringens and anaerobic streptococci isolates, with the exception of Peptostreptococcus anaerobius, were penicillin susceptible. Amoxicillin/clavulanate showed good activity against most anaerobes, but resistance was seen with Bacteroides fragilis group and P. anaerobius isolates. Cefoxitin was more active than cefotetan, particularly...Continue Reading

References

Dec 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P Summanen, H Jousimies-Somer
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E KönönenH Jousimies-Somer
Feb 11, 1998·Clinical Microbiology Reviews·D A Murdoch
Jun 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H NguyenD R Snydman
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E RoeD W Hecht
Aug 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ellie J C Goldstein
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Susan NyforsHannele Jousimies-Somer

❮ Previous
Next ❯

Citations

Sep 18, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y GlupczynskiH Nizet
May 10, 2007·Drugs·George G ZhanelJames A Karlowsky
May 7, 2009·Future Microbiology·Gayatri Vedantam
May 29, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Audrey N Schuetz
Dec 25, 2013·The Journal of Veterinary Medical Science·Yuta KinoshitaKazuhisa Hariu
Dec 1, 2013·Clinical Journal of Gastroenterology·Sho KiritaniNorihiro Kokudo
Nov 6, 2015·The Journal of Antimicrobial Chemotherapy·C Steininger, Birgit Willinger
Sep 15, 2012·Anaerobe·Márcio Garcia RibeiroFrancisco Carlos Faria Lobato
Nov 29, 2011·Anaerobe·Dennis L StevensAmy E Bryant
Jul 30, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yen-Chun ChenMin-Hong Hsieh
Feb 4, 2011·Waste Management·Cristina Dutra VieiraLuiz de Macêdo Farias
Aug 21, 2010·Anaerobe·Yael Shachor-MeyouhasImad Kassis
Mar 19, 2009·Anaerobe·M MarinaT Kantardjiev
Feb 27, 2009·Clinical Therapeutics·S James Matthews, Jason W Lancaster
Jun 19, 2008·Journal of Tissue Viability·Nitish Khanna
Apr 3, 2016·The Journal of Arthroplasty·Scott R NodzoAndy O Miller
Dec 14, 2007·Expert Opinion on Pharmacotherapy·David P Nicolau
Oct 4, 2012·FEMS Microbiology Reviews·Elizabeth Carmel Murphy, Inga-Maria Frick
Sep 26, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Xiaomei WuXinyan Wang
Jul 5, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E Rodríguez-CavalliniM-M Gamboa-Coronado
Mar 28, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sergio Álvarez-PérezMarta E García
Aug 7, 2007·Expert Review of Anti-infective Therapy·Lyudmila BoyanovaIvan Mitov
Jun 6, 2007·Expert Review of Anti-infective Therapy·Alfred GinGeorge G Zhanel
Mar 21, 2017·Dental Clinics of North America·Glendee Reynolds-CampbellCamille-Ann Thoms-Rodriguez
Mar 13, 2017·Enfermedades infecciosas y microbiología clínica·Simón Pedro Lubián-LópezIsabel Benavente-Fernández
Oct 8, 2017·The Veterinary Record·Sara GardhouseMichelle G Hawkins
Jan 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alejandra Ugarte-TorresDeirdre L Church
Dec 19, 2014·Journal of Clinical Microbiology·B J GardinerT M Korman
Nov 22, 2018·Brazilian Journal of Biology = Revista Brasleira De Biologia·E A J SilvaM L D Miranda
Oct 21, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Patrick McGannEmil P Lesho
May 12, 2011·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Rodrigo Pires dos SantosLuciano Zubaran Goldani
Oct 30, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Timothy J WhitmanDavid R Tribble

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.